Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Immunic

Tracked across 3 events · 24 articles · First seen Apr 01, 2026 · Last active Aug 10, 2026

Sentiment
7
Attention
2
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Business
Impact: Immunic will participate in several investor, industry, and scientific conferences in June 2026 to present its pipeline and engage with investors and partners, potentially increasing its visibility and attracting investment.
Jun 10, 2026 · 10 articles
0 0
Business
Impact: Immunic is the company announcing its participation in investor conferences, which is a standard practice to engage with investors and analysts.
Jul 09, 2026 · 8 articles
1 10
Business
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company developing oral therapies for neurologic diseases, announced the appointment of Elena Ridloff, CFA, to its Board of Directors, effective August 6, 2026. Ridloff brings over two decades…
Impact: Immunic is the central entity, appointing a new board member to strengthen its leadership as it approaches pivotal Phase 3 data and potential commercialization.
Aug 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Immunic live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.